Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Clinical Diabetes and Endocrinology|January 6, 2021
Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence studyJianmin Wu, Fritha Morrison, Zhenxiang Zhao, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2021
Porcine Epidemic Diarrhea Virus Membrane Protein Interacted with IRF7 to Inhibit Type I IFN Production during Viral InfectionShasha Li, Zixiang Zhu, Fan Yang, et al.ACS Applied Materials & Interfaces|February 16, 2024
Activity-Based Nitric Oxide-Responsive Porphyrin for Site-Selective and Nascent Cancer AblationSuritra Bandyopadhyay, Zhenxiang Zhao, Amanda K East, et al.Journal of Virology|May 20, 2026
Dysregulation of RIG-I activation by picornavirus 3A proteinXiangle Zhang, Zhenxiang Zhao, Kangli Li, et al.Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.Diabetes, Obesity & Metabolism|March 27, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD StudyMichael G Nanna, Carlos Mena-Hurtado, Victoria Divino, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|May 16, 2015
[Study of negative feedback between wild-type BRAF or RAFV600E and Mps1 in melanoma]Ling Zhang, Chanting He, Yanghui Bi, et al.Diabetes, Obesity & Metabolism|December 20, 2018
A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapyKausik K Ray, David M Kendall, Zhenxiang Zhao, et al.Journal of the American Heart Association|February 11, 2015
Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarctionSuzanne V Arnold, Kim G Smolderen, Kevin F Kennedy, et al.American Journal of Preventive Cardiology|June 15, 2026
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE - primary prevention studyKim G Smolderen, Carlos Mena-Hurtado, Victoria Divino, et al.Pageof 11